As new cases are filed, the current federal case is moving forward. According to the recent March 17th status report, the parties are working to coordinate discovery and case schedules in the federal multidistrict litigation with the many pending state court cases, and document production by a number of defendants is well underway.
The Ahearne Law Firm, PLLC represents Plaintiffs who have experienced heart attacks, strokes and other cardiovascular complications due to testosterone treatments. For a free consultation call The Ahearne Law Firm, PLLC nationwide at (845) 763-4100.
On March 3, 2015, the FDA announced that it will now require the drugs manufacturers to add information to their product labels detailing their potential to increase the risk for heart attacks and strokes. The FDA also expressed concern that these therapies are being used extensively to relieve low testosterone normally associated with aging, and reiterated that the benefits and safety of this use have not been established.
Men who suffered heart attacks, strokes and other serious cardiovascular problems allegedly due to their use of low testosterone therapies may be entitled to take legal action and qualify to file into the in U.S. District Court Northern District of Illinois federal multidistrict litigation case. (In re: Testosterone Replacement Therapy Product Liability Litigation – MDL No. 2545)